Template:Dgfn2015 So xx:00 Molekulare Methoden, neuere
(Difference between revisions)
Ossip Groth (Talk | contribs) (Created page with "==Crispr cas system== {{tp|p=22745249|t=2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity |pdf=http://diyhpl.us/~bryan/papers2/paperbot/A%20...") |
Ossip Groth (Talk | contribs) |
||
Line 5: | Line 5: | ||
{{tp|p=26040877|t=2015. CRISPR, the disruptor |pdf=http://www.nature.com/polopoly_fs/1.17673!/menu/main/topColumns/topLeftColumn/pdf/522020A.pdf|usr=|c=Major bioethical document}} | {{tp|p=26040877|t=2015. CRISPR, the disruptor |pdf=http://www.nature.com/polopoly_fs/1.17673!/menu/main/topColumns/topLeftColumn/pdf/522020A.pdf|usr=|c=Major bioethical document}} | ||
{{tp|p=25894090|t=2015. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes |pdf=http://link.springer.com/content/pdf/10.1007%2Fs13238-015-0153-5.pdf|usr=|First human germline crispr application}} | {{tp|p=25894090|t=2015. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes |pdf=http://link.springer.com/content/pdf/10.1007%2Fs13238-015-0153-5.pdf|usr=|First human germline crispr application}} | ||
− | {{ | + | {{utp|p=26229113|t=2015. BIOSAFETY Safeguarding gene drive experiments in the laboratory |pdf=http://www.sciencemag.org/content/349/6251/927.long|usr=}} |
− | {{tp|p=25908821|t=2015. Genome editing The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations |pdf=http://www.sciencemag.org/content/348/6233/442.long|usr=}} | + | {u{tp|p=25908821|t=2015. Genome editing The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations |pdf=http://www.sciencemag.org/content/348/6233/442.long|usr=}} |
==MicroRNA== | ==MicroRNA== | ||
+ | {{utp|p=21423249|t=2011. MicroRNAs as mediators and therapeutic targets in chronic kidney disease |pdf=http://www.nature.com/nrneph/journal/v7/n5/full/nrneph.2011.26.html|usr=}} | ||
+ | {{utp|p=16258535|t=2005. Silencing of microRNAs in vivo with antagomirs |pdf=http://www.nature.com/nature/journal/v438/n7068/full/nature04303.html|usr=}} | ||
+ | {{tp|p=19289845|t=2009. MicroRNA expression profiles predictive of human renal allograft status |pdf=http://www.pnas.org/content/106/13/5330.full.pdf|usr=}} | ||
+ | {{tp|p=22344686|t=2012. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=22344686&pmc=3672221&ti=MicroRNA-21%20promotes%20fibrosis%20of%20the%20kidney%20by%20silencing%20metabolic%20pathways|usr=}} | ||
+ | {{tp|p=24854275|t=2014. MicroRNA-24 antagonism prevents renal ischemia reperfusion injury |pdf=http://jasn.asnjournals.org/content/25/12/2717.long|usr=}} | ||
+ | {{tp|p=22580786|t=2012. Circulating and urinary microRNAs in kidney disease |pdf=http://cjasn.asnjournals.org/content/7/9/1528.full.pdf|usr=}} | ||
+ | {{tp|p=24743145|t=2014. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy |pdf=http://www.jci.org/articles/view/70577/pdf|usr=}} | ||
+ | {{tp|p=21383194|t=2011. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma |pdf=http://www.pnas.org/content/108/12/5003.full.pdf|usr=}} |
Revision as of 18:26, 21 September 2015
Crispr cas system
Journal article, free access (Hinweis: First description of the cc system) |
GET 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity Extract PDF direct |
Journal article, free access |
GET 2013. Genome engineering using the CRISPR-Cas9 system Extract PDF direct |
Journal article, free access |
GET 2013. Genome engineering using the CRISPR-Cas9 system Extract PDF direct |
Journal article, free access (Hinweis: Major bioethical document) |
GET 2015. CRISPR, the disruptor Extract PDF direct |
Journal article, free access |
GET 2015. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes Extract PDF direct |
Journal Paper, restricted access |
GET 2015. BIOSAFETY Safeguarding gene drive experiments in the laboratory Extract PDF direct |
{u{tp|p=25908821|t=2015. Genome editing The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations |pdf=http://www.sciencemag.org/content/348/6233/442.long%7Cusr=}}
MicroRNA
Journal Paper, restricted access |
GET 2011. MicroRNAs as mediators and therapeutic targets in chronic kidney disease Extract PDF direct |
Journal Paper, restricted access |
GET 2005. Silencing of microRNAs in vivo with antagomirs Extract PDF direct |
Journal article, free access |
GET 2009. MicroRNA expression profiles predictive of human renal allograft status Extract PDF direct |
Journal article, free access |
GET 2012. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways Extract PDF direct |
Journal article, free access |
GET 2014. MicroRNA-24 antagonism prevents renal ischemia reperfusion injury Extract PDF direct |
Journal article, free access |
GET 2012. Circulating and urinary microRNAs in kidney disease Extract PDF direct |
Journal article, free access |
GET 2014. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy Extract PDF direct |
Journal article, free access |
GET 2011. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma Extract PDF direct |